Madam Therapeutics Start-Up Stadium

2:30 PM–2:45 PM Jun 4, 2019 (US - Eastern)

Hall E, Booth 3971, Level 200


Therapeutics company developing synthetic peptides that inhibit the formation of biofilm, commonly associated with bacterial infections, in an effort to combat resistant bacterial infections, which is a growing public health crisis around the world. The peptides create optimal antibacterial conditions that mimic physiological environments in order to enhance wound care and healing. This technology is currently predicted to be an effective treatment to diabetic foot ulcers but is expected to be expanded to other applications in varying medical fields.

Session ID: 531664